Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on May 13, 2010
CRANBURY, N.J., May 13 /PRNewswire-FirstCall/ — Palatin Technologies, Inc. (NYSE Amex: PTN), a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, today announced results for its third quarter ended March 31, 2010. Palatin reported a net loss of $2.0 million, or ($0.02) per basic and diluted share for the …